Stock Research for CLVS

Current Price


Latest Update: 2018-03-19 16:00:00

$ 56.7800
$ 56.6900
$ 56.7500

Featured Broker: TradeStation

Get the due diligence for another stock.


CLVS Stock Chart & Research Data

The CLVS chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the CLVS chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


CLVS Due diligence Resources & Stock Charts

The CLVS stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View CLVS Detailed Price Forecast - CNN Money CNN View CLVS Detailed Summary - Google Finance
Yahoo View CLVS Detailed Summary - Yahoo! Finance Zacks View CLVS Stock Research & Analysis -

Stock Analysis

TradeIdeas View CLVS Trends & Analysis - Trade-Ideas Barrons View CLVS Major Holders - Barrons
NASDAQ View CLVS Call Transcripts - NASDAQ Seeking View CLVS Breaking News & Analysis - Seeking Alpha
Spotlight View CLVS Annual Report - OTC Report View CLVS OTC Short Report -
TradeKing View CLVS Fundamentals - TradeKing Charts View CLVS SEC Filings - Bar Chart
WSJ View Historical Prices for CLVS - The WSJ Morningstar View Performance/Total Return for CLVS - Morningstar
MarketWatch View the Analyst Estimates for CLVS - MarketWatch CNBC View the Earnings History for CLVS - CNBC
StockMarketWatch View the CLVS Earnings - StockMarketWatch MacroAxis View CLVS Buy or Sell Recommendations - MacroAxis
Bullish View the CLVS Bullish Patterns - American Bulls Short Pains View CLVS Short Pain Metrics -

Social Media Mentions

StockTwits View CLVS Stock Mentions - StockTwits PennyStocks View CLVS Stock Mentions - PennyStockTweets
Twitter View CLVS Stock Mentions - Twitter Invest Hub View CLVS Investment Forum News - Investor Hub
Yahoo View CLVS Stock Mentions - Yahoo! Message Board Seeking Alpha View CLVS Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for CLVS - Insider Cow View Insider Transactions for CLVS - Insider Cow
CNBC View CLVS Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for CLVS - OTC Markets
Yahoo View Insider Transactions for CLVS - Yahoo! Finance NASDAQ View Institutional Holdings for CLVS - NASDAQ

Stock Charts

FinViz View CLVS Stock Insight & Charts - StockCharts View CLVS Investment Charts -
BarChart View CLVS Stock Overview & Charts - BarChart Trading View View CLVS User Generated Charts - Trading View

Latest Financial News for CLVS

Edited Transcript of CLVS earnings conference call or presentation 26-Feb-18 9:30pm GMT
Posted on Thursday March 15, 2018

Q4 2017 Clovis Oncology Inc Earnings Call

See what the IHS Markit Score report has to say about Clovis Oncology Inc.
Posted on Tuesday March 13, 2018

Short interest is moderately high for CLVS with between 10 and 15% of shares outstanding currently on loan. This represents an increase in short interest as investors who seek to profit from falling equity prices added to their short positions on January 29.

AstraZeneca Goes Up Against 2 Cancer Upstarts
Posted on Friday March 09, 2018

Tesaro and Clovis Oncology hope to unseat the big pharma giant, but they've got their work cut out for them.

Clovis Oncology Announces Notice of Allowance for Rucaparib High Dosage Strength Tablet Patent with Expiration in 2035
Posted on Thursday March 08, 2018

Clovis Oncology, Inc. announced today that the Company has received a Notice of Allowance from the United States Patent and Trademark Office in United States Patent Application 14/828,065 with claims directed to high dosage strength rucaparib camsylate formulations.

Warning: DOMDocument::load(): StartTag: invalid element name in, line: 1 in /home/allsites/ on line 494

Warning: DOMDocument::load(): Extra content at the end of the document in, line: 1 in /home/allsites/ on line 494

Enter a stock symbol to view the stock details.